probenecid has been researched along with Diabetes Mellitus, Adult-Onset in 5 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Richette, P | 1 |
Perez-Ruiz, F | 1 |
Doherty, M | 1 |
Jansen, TL | 1 |
Nuki, G | 1 |
Pascual, E | 1 |
Punzi, L | 1 |
So, AK | 1 |
Bardin, T | 1 |
McCarty, MF | 1 |
Edwards, J | 1 |
Green, P | 1 |
Haase, D | 1 |
Hisatome, I | 1 |
Sasaki, N | 1 |
Yamakawa, M | 1 |
Kobayashi, M | 1 |
Tanaka, Y | 1 |
Kosaka, H | 1 |
Yoshida, A | 1 |
Kotake, H | 1 |
Mashiba, H | 1 |
Takeda, A | 1 |
Shichiri, M | 1 |
Iwamoto, H | 1 |
Shiigai, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Allopurinol in the Treatment of Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Treated by Either PCI or CABG: Pilot Study[NCT03700645] | Phase 4 | 100 participants (Anticipated) | Interventional | 2018-12-01 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for probenecid and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Improving cardiovascular and renal outcomes in gout: what should we target?
Topics: Allopurinol; Cardiovascular Diseases; Colchicine; Diabetes Mellitus, Type 2; Disease Management; Gou | 2014 |
4 other studies available for probenecid and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Potential utility of natural polyphenols for reversing fat-induced insulin resistance.
Topics: Adipocytes; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Flavonoids; Humans; I-kappa B Kin | 2005 |
A blistering disease: bullous erysipelas.
Topics: Anti-Bacterial Agents; Blister; Cefazolin; Cellulitis; Diabetes Mellitus, Type 2; Erysipelas; Humans | 2006 |
Two cases of persistent hypouricemia associated with diabetes mellitus.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Humans; Kidney Tubules; Male; Probenecid | 1992 |
Diabetic renal hypouricemia.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Tubules; Male; Midd | 1987 |